• What we do
  • The People
  • About Us
  • Why Innovation Africa
  • Contact Us
Innovation AfricaCreating the Future Today
  • Feature Articles
  • Innovation
  • Agriculture
  • ICT
  • Technology
  • Entrepreneurship
  • Health
  • Store
  • Contact Us
Menu
  • Feature Articles
  • Innovation
  • Agriculture
  • ICT
  • Technology
  • Entrepreneurship
  • Health
  • Store
  • Contact Us
  • Modified vaccine shows promise in preventing malaria

    September 26, 2011 Editor 0

    Modified vaccine shows promise in preventing malaria

    Vaccine uses immune-stimulating gene

    EAST LANSING, Mich. — Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine – one that combines the use of a disabled cold virus with an immune system-stimulating gene – that appears to increase the immune response against the parasite that causes the deadly disease.

    At the same time, the group led by Andrea Amalfitano of the College of Osteopathic Medicine also discovered another immune-system stimulating agent – created at MSU and which has been successful in improving immune responses in vaccines for diseases such as HIV – paradoxically made for a less effective malaria vaccine.

    Both of the findings will help researchers develop more effective vaccine platforms in general, and malaria vaccines specifically, hopefully leading to human clinical trials soon, Amalfitano said. The research is published in the current edition of PLoS ONE.

    “Researchers across the globe are working on ways to prevent people from becoming infected with malaria,” said Amalfitano of the disease that kills up to a million people each year, mainly in sub-Saharan Africa. “Some vaccines are showing promise, but they are not as effective as they need to be for any mass distribution.”

    Amalfitano and his research team are focusing on one such vaccine platform, spearheaded by the U.S. Army, that targets a certain gene on the malaria parasite, a protein called Circumsporozoite Protein, or CSP.

    That protein is thought to play a key role in creating an immune response to the malaria parasite; past research shows people infected by malaria multiple times will begin creating an immune response to this protein, suggesting at some level it could be protective.

    “What we are looking to do is improve the ability of the vaccine to induce immune responses to that protein,” Amalfitano said. “We are adding genes to the vaccine to try and stimulate the immune system.”

    Those genetic agents, similar to chemical adjuvants, are stimulants that improve the ability of vaccines to induce beneficial.

    In mouse models, the researchers used two such “gene-adjuvants”: rEA and EAT-2, both of which aimed to illicit improved immune responses to the malaria CSP gene. Surprisingly, the rEA agent – which was developed at MSU in part by the late Barnett Rosenberg – did not produce the desired result and in fact seemed to worsen the animal’s ability to generate an immune response to CSP.

    However, the EAT-2 gene-adjuvant stimulated the immune system in a different way, and Amalfitano and his team were able to increase the ability of the immune system to respond to CSP to a level that surpassed currently available malaria vaccine systems.

    “The results were surprising, but we were able to hit our goal eventually,” he said. “This research will help us as we create a viable vaccine. While the way that rEA is trying to stimulate the immune system may not be the best way for malaria, we did come up with an alternative adjuvant to effectively target the parasite.”

    Amalfitano said the next step is to see if researchers can prevent malaria in animal models using the EAT-2 gene-adjuvant: “Then we can take the lessons learned and really go forward and do what’s necessary to feel confident to begin human trials.”

    Related Posts

    • Malaria vaccines: The long warMalaria vaccines: The long war
    • First results from Phase 3 trial show malaria vaccine candidate reduces the risk of malariaFirst results from Phase 3 trial show malaria vaccine candidate reduces the risk of malaria
    • Modernizing education: You can’t find a job in your textbook
    • How Decisions Can Be Organized – and Why It MattersHow Decisions Can Be Organized – and Why It Matters
    • Africa: Taxing the Continent’s Internet GenerationAfrica: Taxing the Continent’s Internet Generation
    • Social Media Can Play a Role in Business Process Management
    Sovrn
    Share

    Categories: Health

    Tags: malaria vaccine

    U of T-led research improves performance of next-generation solar cell technology Two Questions on the Sustainability of Grameen’s Android App for Farmers

    Leave a Reply Cancel reply

    You must be logged in to post a comment.

Subscribe to our stories


 

Recent Posts

  • Entrepreneurial Alertness, Innovation Modes, And Business Models in Small- And Medium-Sized Enterprises December 30, 2021
  • The Strategic Role of Design in Driving Digital Innovation June 10, 2021
  • Correction to: Hybrid mosquitoes? Evidence from rural Tanzania on how local communities conceptualize and respond to modified mosquitoes as a tool for malaria control June 10, 2021
  • BRIEF FOCUS: Optimal spacing for groundnuts in smallholder farming systems June 9, 2021
  • COVID-19 pandemic: impacts on the achievements of Sustainable Development Goals in Africa June 9, 2021

Categories

Archives

Popular Post-All time

  • A review on biomass-based... 1k views
  • Can blockchain disrupt ge... 762 views
  • Apply Now: $500,000 for Y... 755 views
  • Prize-winning projects pr... 716 views
  • Test Your Value Propositi... 688 views

Recent Posts

  • Entrepreneurial Alertness, Innovation Modes, And Business Models in Small- And Medium-Sized Enterprises
  • The Strategic Role of Design in Driving Digital Innovation
  • Correction to: Hybrid mosquitoes? Evidence from rural Tanzania on how local communities conceptualize and respond to modified mosquitoes as a tool for malaria control
  • BRIEF FOCUS: Optimal spacing for groundnuts in smallholder farming systems
  • COVID-19 pandemic: impacts on the achievements of Sustainable Development Goals in Africa
  • Explicit knowledge networks and their relationship with productivity in SMEs
  • Intellectual property issues in artificial intelligence: specific reference to the service sector
  • Africa RISING publishes a livestock feed and forage production manual for Ethiopia
  • Transforming crop residues into a precious feed resource for small ruminants in northern Ghana
  • Photo report: West Africa project partners cap off 2020 with farmers field day events in Northern Ghana and Southern Mali

Tag Cloud

    africa African Agriculture Business Business model Business_Finance Company Crowdsourcing data Development East Africa economics Education Entrepreneur entrepreneurs Entrepreneurship ethiopia ghana Health_Medical_Pharma ict Information technology Innovation kenya knowledge Knowledge Management Leadership marketing mobile Mobile phone nigeria Open innovation Organization Research rwanda science Science and technology studies social enterprise social entrepreneurship south africa Strategic management strategy tanzania Technology Technology_Internet uganda

Categories

Archives

  • A review on biomass-based hydrogen production for renewable energy supply 1k views
  • Can blockchain disrupt gender inequality? 762 views
  • Apply Now: $500,000 for Your Big Data Innovations in Agriculture 755 views
  • Prize-winning projects promote healthier eating, smarter crop investments 716 views
  • Test Your Value Proposition: Supercharge Lean Startup and CustDev Principles 688 views

Copyright © 2005-2020 Innovation Africa Theme created by PWT. Powered by WordPress.org